Status:

COMPLETED

Treatment of Recurrent Hepatitis C After Liver Transplantation

Lead Sponsor:

Rennes University Hospital

Collaborating Sponsors:

Ministry of Health, France

ANRS, Emerging Infectious Diseases

Conditions:

Liver Transplantation

Hepatitis C

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

In France, 50% of the hepatitis C virus carriers develop chronic clinical hepatitis, which may lead to cirrhosis and liver transplantation. Transplant infection by hepatitis C virus is constant after ...

Detailed Description

Several therapeutic patterns have been described for the treatment of hepatitis C post-transplantation recurrence. A combination treatment associating interferon-α and ribavirin has shown some efficac...

Eligibility Criteria

Inclusion

  • First liver transplantation or retransplantation in the month after initial transplantation
  • Patients aged over 18 years
  • Post-hepatitis C cirrhosis
  • Equilibrated immunosuppressive treatment
  • Positive PCR for hepatitis C virus
  • Liver biopsy between 6 months and 5 years after the transplantation with a fibrosis Metavir score at least F1
  • Hemoglobin ≥ 10 g/dl
  • Platelet count ≥ 50.000/mm3
  • Normal TSH value
  • Serum creatinine \< 200µmol/l
  • Informed written consent

Exclusion

  • Chronic rejection
  • Acute rejection at inclusion
  • Multi-visceral transplantation
  • Renal or cardiac failure, severe sepsis
  • Uncontrolled diabetes
  • Positive serology for hepatitis B or HIV at inclusion
  • EBV virus replication at inclusion
  • Hepatocellular carcinoma at inclusion
  • Cirrhosis with a fibrosis Metavir score F4 at inclusion
  • Inclusion in another clinical trial less than one month ago
  • Pregnancy
  • Contra-indication to ribavirin or interferon
  • History of or current psychiatric troubles
  • Thyroid disease uncontrolled by treatment

Key Trial Info

Start Date :

February 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2006

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00151580

Start Date

February 1 2002

End Date

July 1 2006

Last Update

May 21 2012

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Service d'Hépatologie - Hôpital Jean Minjoz

Besançon, France, 25030

2

Service de Chirurgie Digestive - Groupe Hospitalier Pellerin-Tripode

Bordeaux, France, 33000

3

Service d'Hépatogastroentérologie - Hôpital Beaujon

Clichy, France, 92110

4

Service d'Hépatologie et Gastroentérologie - Hôpital Henri Mondor

Créteil, France, 94010

Treatment of Recurrent Hepatitis C After Liver Transplantation | DecenTrialz